Fukuda Denshi : Notice of the Forecast of the Financial Results and Dividends for the Fiscal Year Ending March 2022
February 28, 2022 at 04:12 am EST
Share
January 31st, 2022
Company name: Fukuda Denshi Co., Ltd.
Representative: Daijiro Shirai, President & COO
JASDAQ code no.: 6960
Inquiries: Business Planning Department
Telephone: +81-3-5684-1558
Notice of the Forecast of the Financial Results
for the Fiscal Year Ending March 2022
Fukuda Denshi has revised the forecasts of the financial results for the fiscal year ending March 31st, 2022 based on the recent business conditions.
1. Forecast of consolidated financial results for the fiscal year ending March 2022 (April 1st, 2021 through March 31st, 2022)
(% represents increase or decrease from the previous forecast)
Profit
Net sales
Operating
Ordinary
attributable
Earnings
Profit
Profit
to owners of
per share
parent
million yen
million yen
million yen
million yen
yen
Previous forecast (A)
125,000
15,000
15,000
11,000
727.52
This forecast (B)
125,000
20,000
20,500
15,000
991.96
Fluctuation sum (B-A)
0
+5,000
+5,500
+4,000
Fluctuation rate (%)
0.0
+33.3
+36.7
+36.4
(Rf) Previous FY
146,756
19,811
20,264
14,716
973.33
ended March 2021
2. Reasons for revisions
The consolidated "Net sales" and the "Profit" increased due to the expansion of COVID-19 related products and the continued efforts to improve profitability.
As the results, forecast of consolidated "Operating Profit", "Ordinary Profit", and "Profit attributable to owners of parent" exceeds the previous forecast.
There is no change to the forecast of "Net sales" considering the impact of the decrease of the number of large orders.
※Note
The forecasted financial results described above are based on information available as of the release date of this announcement. Actual results may differ from the results projected and presented hereby for a variety of reasons.
1
It will be promptly announced as soon as the revision of the forecast is needed.
※This English translation is for reference purposes only. The original Japanese version will prevail as the official authoritative version.
※The original disclosure in Japanese was released on January 31st, 2022 at 15:00 (GMT+9)
2
Attachments
Original Link
Original Document
Permalink
Disclaimer
Fukuda Denshi Co. Ltd. published this content on 28 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 February 2022 09:11:07 UTC.
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
FUKUDA DENSHI CO., LTD. 
